X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
ACTAVIS
Dec-14
SUVEN LIFE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs22918,501-   
Low Rs15111,285-   
Sales per share (Unadj.) Rs42.73,331.6-  
Earnings per share (Unadj.) Rs6.9-415.7-  
Cash flow per share (Unadj.) Rs8.5305.7-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs52.47,226.1-  
Shares outstanding (eoy) m127.28265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.5 99.4%   
Avg P/E ratio x27.7-35.8 -77.3%  
P/CF ratio (eoy) x22.248.7 45.7%  
Price / Book Value ratio x3.62.1 175.7%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m24,1583,960,121 0.6%   
No. of employees `0001.021.6 4.7%   
Total wages/salary Rs m5220-   
Avg. sales/employee Rs Th5,349.741,012.3 13.0%   
Avg. wages/employee Rs Th513.50-   
Avg. net profit/employee Rs Th858.1-5,117.9 -16.8%   
INCOME DATA
Net Sales Rs m5,435885,865 0.6%  
Other income Rs m211-2,211 -9.5%   
Total revenues Rs m5,646883,654 0.6%   
Gross profit Rs m1,291113,802 1.1%  
Depreciation Rs m214191,822 0.1%   
Interest Rs m5727,942 0.2%   
Profit before tax Rs m1,231-108,173 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,935 0.0%   
Tax Rs m359-5,561 -6.5%   
Profit after tax Rs m872-110,547 -0.8%  
Gross profit margin %23.712.8 184.8%  
Effective tax rate %29.25.1 567.1%   
Net profit margin %16.0-12.5 -128.5%  
BALANCE SHEET DATA
Current assets Rs m4,917466,737 1.1%   
Current liabilities Rs m1,186340,389 0.3%   
Net working cap to sales %68.614.3 481.3%  
Current ratio x4.11.4 302.4%  
Inventory Days Days6258 107.1%  
Debtors Days Days3166 46.4%  
Net fixed assets Rs m3,154108,173 2.9%   
Share capital Rs m1270-   
"Free" reserves Rs m6,5430-   
Net worth Rs m6,6701,921,408 0.3%   
Long term debt Rs m2591,006,856 0.0%   
Total assets Rs m8,1573,521,309 0.2%  
Interest coverage x22.7-2.9 -789.4%   
Debt to equity ratio x00.5 7.4%  
Sales to assets ratio x0.70.3 264.9%   
Return on assets %11.4-2.3 -485.3%  
Return on equity %13.1-5.8 -227.2%  
Return on capital %18.6-3.0 -617.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,0370-   
CASH FLOW
From Operations Rs m1,088152,120 0.7%  
From Investments Rs m-3,107-364,234 0.9%  
From Financial Activity Rs m-300204,647 -0.1%  
Net Cashflow Rs m-2,319-7,467 31.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare SUVEN LIFE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE With: LUPIN LTD  FULFORD INDIA  CIPLA  J.B.CHEMICALS  PFIZER  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 25, 2018 01:03 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS